| http://www.w3.org/ns/prov#value | - When the compound has a basic functional group, it can be in the form of a pharmaceutically acceptable salt. [0052] In one embodiment, P is a peptide capable of interacting with at least one region of a fibril or amyloid protein. [0053] In a preferred embodiment of the present invention, the subject is a human being. [0054] In yet another embodiment of the present invention, the amyloid related di
|
